ISRAEL AT WAR - DAY 66

search

Visiting Jerusalem, US senator says Biden will submit Iran deal to congressional approval

Jeremy Sharon is The Times of Israel’s legal affairs and settlements reporter

US Senators including Lindsey Graham and Bob Menendez (center) at a press conference in Jerusalem on September 5, 2022. (Jeremy Sharon)
US Senators including Lindsey Graham and Bob Menendez (center) at a press conference in Jerusalem on September 5, 2022. (Jeremy Sharon)

Chairman of the US Senate Foreign Relations Committee Robert Menendez says that the Biden administration has committed to submitting any agreement on Iran’s nuclear program to Congress for review.

Speaking at a press conference in Jerusalem, Menendez says a review would be conducted by his committee and that there would be a vote on such a deal, although said he was unsure if the outcome of that vote “would meet the threshold under the law to nullify the agreement.”

US Senator Lindsey Graham adds that US support for Israel will remain unchanged regardless of the outcome of upcoming midterm elections in the US for Congress.

“No matter what happens in November, the assistance that Israel enjoys from the American government will continue,” says Graham during a press conference at the King David Hotel in Jerusalem. “The relationship between the US and Israel will remain strong and unshakable.”

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.